Ladiratuzumab (hLIV22) 是一种抗 LIV-1/ZIP6 的人源化单克隆抗体。Ladiratuzumab 与微管干扰剂 MMAE (HY-15162) 偶联，能够合成一种抗体-活性分子偶联物 (ADC) SGN-LIV1A。Ladiratuzumab 可用于乳腺癌的研究。

8-Prenylkaempferol is an effective agent for attenuating pro-inflammatory NO induction, it may be an anti-inflammatory agent for suppressing influenza A virus-induced RANTES production acts by blocking PI3K-mediated transcriptional activation of NF-κB and IRF-3 and in part by interfering with IκB degradation which subsequently decreases NF-κB translocation.

Pulchinenoside E2 (Compound 8) 是从 Pulsatilla chinensis 的根中分离出的三萜皂苷。Pulchinenoside E2 对 HL-60 白血病细胞具有细胞毒性，IC50 值为 2.6 μg/mL。